Dement Neurocogn Disord.  2015 Dec;14(4):137-142. 10.12779/dnd.2015.14.4.137.

Constructing a Composite Score for the Seoul Neuropsychological Screening Battery-Core

• Jahng S
• Na DL
• Kang Y

• KMID: 2442930
• DOI: http://doi.org/10.12779/dnd.2015.14.4.137

Abstract

BACKGROUND AND PURPOSE
The brief version of the Seoul Neuropsychological Screening Battery (SNSB), the SNSB-Core (SNSB-C), has been developed. Although each subtest score of the SNSB-C provides information on different features of broad cognitive functioning or impairment, a composite score is needed to identify the severity of global cognitive impairment. We aimed to develop and validate a composite score of the SNSB-C that would provide a normative-based summary score of global cognitive functioning, especially for differentiating patients with cognitive impairment from normal elderly.
METHODS
A normative sample of 1067 elderly was used to develop a composite score of SNSB-C. The composite score was corrected for the effects of age, years of education, and sex by the regression method. Patients with Alzheimer's disease (n=41), vascular dementia (n=40), amnestic mild cognitive impairment (MCI) (n=73), vascular MCI (n=41), and Parkinson's disease with MCI (n=41) were differentiated from a normal sample (n=70) by the uncorrected and corrected composite scores using receiver operating characteristic (ROC) curve analysis.
RESULTS
Confirmatory factor analysis showed that the composite score equal weight to each standardized cognitive domain of SNSB-C is appropriate for indexing overall cognitive functioning. The corrected and uncorrected composite scores yielded a satisfactory size of the area under the ROC curve comparable to the Mini Mental State Examination (MMSE).
CONCLUSIONS
The composite scores of SNSB-C, especially the corrected score, provide an index of overall cognitive functioning, and they can be used as an alternative to MMSE for screening patients with cognitive impairment.

Keyword

Seoul Neuropsychological Screening Battery; Seoul Neuropsychological Screening Battery-Core; composite score; Mini Mental State Examination

MeSH Terms

Abstracting and Indexing as Topic
Aged
Alzheimer Disease
Dementia, Vascular
Education
Humans
Mass Screening*
Mild Cognitive Impairment
Parkinson Disease
ROC Curve
Seoul*

Reference

1. Kang Y, Na DL. Seoul Neuropsychological Screening Battery. Incheon: Human Brain Research & Consulting Co.;2003.

2. Kang Y, Jahng S, Na DL. Seoul Neuropsychological Screening Battery, 2nd Edition (SNSB-II). Seoul: Human Brain Research & Consulting Co.;2012.

3. Kang Y, Jahng S, Na DL. Seoul Neuropsychological Screening Battery-Core (SNSB-C). Incheon: Human Brain Research & Consulting Co.;2015.

4. Kang Y, Chin JH, Na DL. A normative study of the digit span test for the elderly. Korean J Clin Psychol. 2002; 21:911–922.

5. Kang Y, Kim H, Na DL. A short form of the KoreanBoston Naming Test (K-BNT) for using in dementia patients. Korean J Clin Psychol. 1999; 18:125–138.

6. Meyers JE, Meyers KR. Rey Complex Figure Test and Recognition Trial: Professional manual. Odessa, FL: Psychological Assessment Resources;1995.

7. Lee JH, Kang Y, Na DL. Efficiencies of stroop interference indexes in healthy older adults and dementia patients. Korean J Clin Psychol. 2000; 19:807–818.

8. Kang Y, Chin JH, Na DL, Lee JH, Park JS. A normative study of the Korean version of Controlled Oral Word Association Test (COWAT) in the elderly. Korean J Clin Psychol. 2000; 19:385–392.

9. Yi H, Chin JH, Lee BH, Kang Y, Na DL. Development and validation of Korean version of Trail Making Test for elderly persons. Dement Neurocognitive Disord. 2007; 6:54–66.

10. Joy S, Kaplan E, Fein D. Speed and memory in the WAIS-III Digit Symbol--Coding subtest across the adult lifespan. Arch Clin Neuropsychol. 2004; 19:759–767.

11. Christensen KJ, Multhaup KS, Nordstrom S, Voss K. A cognitive battery for dementia: development and measurement characteristics. Psychol Assess. 1991; 3:168–174.

12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34:939–944.

13. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43:250–260.

14. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001; 58:1985–1992.

15. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42:2672–2713.

16. Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012; 27:349–356.

17. Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997; 15:300–308.

18. Salthouse TA, Atkinson TM, Berish DE. Executive functioning as a potential mediator of age-related cognitive decline in normal adults. J Exp Psychol Gen. 2003; 132:566–594.

19. van Hooren SA, Valentijn AM, Bosma H, Ponds RW, van Boxtel MP, Jolles J. Cognitive functioning in healthy older adults aged 64-81: a cohort study into the effects of age, sex, and education. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007; 14:40–54.

20. Caplan PJ, Crawford M, Hyde JS, Richardson JT. Gender differences in human cognition. New York: Oxford University Press;1997.

21. Jahng S, Kang Y. A model-based approach to estimating psychological test norms under normality assumption. Korean J Clin Psychol. 2012; 31:923–944.

22. Goldman JG, Litvan I. Mild cognitive impairment in Parkinson's disease. Minerva Med. 2011; 102:441–459.

23. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006; 37:2220–2241.